Oxbow Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.24M | Buy |
11,698
+92
| +0.8% | +$31.5K | 0.34% | 82 |
|
|
2026
Q1 | $4.08M | Sell |
11,606
-12
| -0.1% | -$4.28K | 0.35% | 78 |
|
|
2025
Q4 | $3.8M | Buy |
11,618
+280
| +2% | +$88.8K | 0.33% | 82 |
|
|
2025
Q3 | $3.2M | Buy |
11,338
+174
| +2% | +$50.5K | 0.3% | 84 |
|
|
2025
Q2 | $3.12M | Buy |
11,164
+232
| +2% | +$65.7K | 0.34% | 73 |
|
|
2025
Q1 | $3.41M | Buy |
10,932
+9,803
| +868% | +$2.89M | 0.36% | 63 |
|
|
2024
Q4 | $294K | Buy |
1,129
+21
| +2% | +$6.23K | 0.03% | 171 |
|
|
2024
Q3 | $357K | Hold |
1,108
| – | – | 0.04% | 157 |
|
|
2024
Q2 | $346K | Hold |
1,108
| – | – | 0.04% | 171 |
|
|
2024
Q1 | $315K | Buy |
1,108
+300
| +37% | +$87.8K | 0.04% | 171 |
|
|
2023
Q4 | $233K | Sell |
808
-10
| -1% | -$2.73K | 0.04% | 185 |
|
|
2023
Q3 | $220K | Sell |
818
-2,741
| -77% | -$684K | 0.03% | 187 |
|
|
2023
Q2 | $790K | Hold |
3,559
| – | – | 0.12% | 94 |
|
|
2023
Q1 | $860K | Buy |
3,559
+83
| +2% | +$20.4K | 0.15% | 89 |
|
|
2022
Q4 | $913K | Sell |
3,476
-375
| -10% | -$101K | 0.17% | 85 |
|
|
2022
Q3 | $868K | Buy |
3,851
+497
| +15% | +$120K | 0.14% | 108 |
|
|
2022
Q2 | $816K | Buy |
3,354
+401
| +14% | +$98.3K | 0.12% | 115 |
|
|
2022
Q1 | $714K | Buy |
2,953
+73
| +3% | +$16.8K | 0.07% | 145 |
|
|
2021
Q4 | $648K | Buy |
2,880
+75
| +3% | +$15.8K | 0.06% | 161 |
|
|
2021
Q3 | $596K | Buy |
2,805
+1,090
| +64% | +$251K | 0.06% | 182 |
|
|
2021
Q2 | $418K | Buy |
1,715
+305
| +22% | +$75K | 0.04% | 214 |
|
|
2021
Q1 | $351K | Hold |
1,410
| – | – | 0.04% | 224 |
|
|
2020
Q4 | $324K | Hold |
1,410
| – | – | 0.04% | 210 |
|
|
2020
Q3 | $358K | Hold |
1,410
| – | – | 0.05% | 203 |
|
|
2020
Q2 | $333K | Buy |
1,410
+70
| +5% | +$16K | 0.05% | 215 |
|
|
2020
Q1 | $272K | Hold |
1,340
| – | – | 0.05% | 222 |
|
|
2019
Q4 | $323K | Hold |
1,340
| – | – | 0.04% | 238 |
|
|
2019
Q3 | $259K | Sell |
1,340
-105
| -7% | -$20.2K | 0.03% | 241 |
|
|
2019
Q2 | $266K | Buy |
1,445
+105
| +8% | +$18.8K | 0.03% | 250 |
|
|
2019
Q1 | $255K | Hold |
1,340
| – | – | 0.03% | 243 |
|
|
2018
Q4 | $261K | Hold |
1,340
| – | – | 0.03% | 234 |
|
|
2018
Q3 | $278K | Sell |
1,340
-50
| -4% | -$9.85K | 0.03% | 237 |
|
|
2018
Q2 | $257K | Hold |
1,390
| – | – | 0.03% | 247 |
|
|
2018
Q1 | $237K | Buy |
1,390
+34
| +3% | +$6.24K | 0.05% | 190 |
|
|
2017
Q4 | $236K | Buy |
1,356
+71
| +6% | +$12.6K | 0.04% | 207 |
|
|
2017
Q3 | $240K | Buy |
+1,285
| New | +$228K | 0.05% | 201 |
|
|
2017
Q1 | – | Sell |
-14,457
| Closed | -$2.11M | – | 246 |
|
|
2016
Q4 | $2.11M | Sell |
14,457
-783
| -5% | -$118K | 0.26% | 100 |
|
|
2016
Q3 | $2.54M | Sell |
15,240
-634
| -4% | -$107K | 0.35% | 86 |
|
|
2016
Q2 | $2.42M | Sell |
15,874
-1,624
| -9% | -$252K | 0.35% | 90 |
|
|
2016
Q1 | $2.62M | Sell |
17,498
-739
| -4% | -$110K | 0.37% | 77 |
|
|
2015
Q4 | $2.96M | Buy |
18,237
+4,308
| +31% | +$677K | 0.37% | 83 |
|
|
2015
Q3 | $1.93M | Buy |
+13,929
| New | +$2.2M | 0.32% | 95 |
|
Other funds holding AMGN
Oxbow Advisors's AMGN Position: Q2 2026 in Review
Oxbow Advisors increased its Amgen (AMGN) stake by 0.79% in Q2 2026, buying an estimated $31.5K and bringing the position to 11,698 shares worth $4.24M. The position accounts for 0.34% of the portfolio, ranked #82.
Oxbow Advisors first reported a position in AMGN in Q3 2015 and has held it in 42 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Oxbow Advisors held 11,698 shares of Amgen worth $4.24M as of Q2 2026.
- Oxbow Advisors bought 92 Amgen shares in Q2 2026, an estimated $31.5K.
- Amgen made up 0.34% of Oxbow Advisors's portfolio in Q2 2026, its #82 holding.
- Oxbow Advisors first reported a position in Amgen in Q3 2015 and has held it in 42 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Oxbow Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.